MedTrace Logo

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology

NCT05781295 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2026-02-20

No results posted yet for this study

Summary

Interest of a Taurolidine lock at each catheter closure in the primary prevention of catheter-related endoluminal infection in paediatric oncology.

Multicentric, controlled, randomized and double-blind label study.

Conditions

  • Children
  • Medical Device
  • Primary Prevention
  • Oncology

Interventions

DEVICE

TaurolockTM

The patient will be followed up to a maximum of 6 months after randomization after have a TaurolockTM injected each time catheter will be used.

DEVICE

Physiological serum

The patient will be followed up to a maximum of 6 months after randomization after have a Physiological serum injected each time catheter will be used.

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Camille CORDERO, MD · Institut Curie

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-19
Primary Completion
2028-07-23
Completion
2028-07-23

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05781295 on ClinicalTrials.gov